Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir ( DrugBank: Zidovudine, Lamivudine, Abacavir )


1 disease
IDDisease name (Link within this page)Number of trials
325Hereditary autoinflammatory syndrome1

325. Hereditary autoinflammatory syndrome


Clinical trials : 7 Drugs : 16 - (DrugBank : 6) / Drug target genes : 2 - Drug target pathways : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02363452
(ClinicalTrials.gov)
September 10, 201515/1/2015Reverse Transcriptase Inhibitors in AGSA Pilot Clinical Trial of Reverse Transcriptase Inhibitors in Children With Aicardi-Goutières Syndrome (AGS)Aicardi-Goutières Syndrome (AGS)Drug: Reverse transcriptase inhibitors: Zidovudine, Lamivudine, AbacavirAssistance Publique - Hôpitaux de ParisNULLCompleted1 Month17 YearsAll11Phase 2France